New biomimetic formulation developed to tackle glioblastoma multiforme

By | July 22, 2022
Glioblastoma multiforme (GBM) is an aggressive brain cancer with a poor prognosis and few treatment options. New and effective approaches for GBM treatment are therefore urgently needed.